- $2.02m
- -$0.13m
- $18.32m
- 55
- 100
- 30
- 65
Annual income statement for Trucept, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 June 30th | 2011 December 31st | 2012 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | PRESS | PRESS |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Other Revenue | |||||
| Total Revenue | 12.1 | 21.7 | 27.7 | 20.1 | 18.3 |
| Cost of Revenue | |||||
| Gross Profit | 3.52 | 0.943 | 1.1 | 13.7 | 12.2 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 11.9 | 27.9 | 35 | 18.8 | 16.5 |
| Operating Profit | 0.213 | -6.19 | -7.3 | 1.28 | 1.83 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.203 | -8.12 | -7.85 | 1.52 | 1.56 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.203 | -8.12 | -7.85 | 1.52 | 1.56 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 0.203 | -8.12 | -7.85 | 1.52 | 1.56 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 0.203 | -8.12 | -7.85 | 1.52 | 1.56 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.004 | -0.209 | -0.16 | 0.028 | 0.028 |
| Dividends per Share |